Cargando…

Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway

Lung cancer is the most common malignant tumor type and it is associated with poor prognosis. The identification of potential biomarkers is of great significance for the early diagnosis and treatment of lung cancer. Non-small cell lung cancer (NSCLC) is the most common pathological type of lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Rujian, Zhou, Qian, Ju, Linling, Chen, Lin, Wang, Feng, Shao, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261194/ https://www.ncbi.nlm.nih.gov/pubmed/34184074 http://dx.doi.org/10.3892/or.2021.8123

Ejemplares similares

TRIP 13-dependent pathways promote the development of gastric cancer
por: Ni, Fengming, et al.
Publicado: (2023)

Hsa_circRNA_100146 Promotes Prostate Cancer Progression by Upregulating TRIP13 via Sponging miR-615-5p
por: Zeng, Liang, et al.
Publicado: (2021)

TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
por: Lu, Wang, et al.
Publicado: (2022)

Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression
por: Ju, Linling, et al.
Publicado: (2022)

HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2
por: Yin, Jiangyan, et al.
Publicado: (2021)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
por: Xiao, Zhangxian, et al.
Publicado: (2023)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
por: Xie, Qiubo, et al.
Publicado: (2020)

Disassembly of the Shieldin Complex by TRIP13
por: Sarangi, Prabha, et al.
Publicado: (2020)

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

An acid trip activates protumoral macrophages to promote hepatocellular carcinoma malignancy
por: Graham, Nicola, et al.
Publicado: (2022)

Insights into a Crucial Role of TRIP13 in Human Cancer
por: Lu, S., et al.
Publicado: (2019)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018)

Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways
por: Lan, Jin, et al.
Publicado: (2022)

UNC13C Suppress Tumor Progression via Inhibiting EMT Pathway and Improves Survival in Oral Squamous Cell Carcinoma
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019)

Trip and Trip Pro
por: Fox, Lynne M.
Publicado: (2018)

DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in colorectal cancer
por: Agarwal, Sumit, et al.
Publicado: (2022)

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
por: Wang, Yingcong, et al.
Publicado: (2023)

CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition
por: Zhang, Ruijie, et al.
Publicado: (2022)

Upregulation of TMEM40 is associated with the malignant behavior and promotes tumor progression in cervical cancer
por: Zhang, Zhen-Fei, et al.
Publicado: (2023)

TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status
por: Agarwal, Sumit, et al.
Publicado: (2020)

PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
por: Zhang, Hanpu, et al.
Publicado: (2022)

Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway
por: Gao, Yanjun, et al.
Publicado: (2019)

Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer
por: Hori, Satoshi, et al.
Publicado: (2017)

Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling
por: You, Xiaolan, et al.
Publicado: (2019)

Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
por: Wörthmüller, Janine, et al.
Publicado: (2018)

Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression
por: Wang, D, et al.
Publicado: (2017)

AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer
por: Xu, Fen, et al.
Publicado: (2020)

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
por: Zhao, Liwen, et al.
Publicado: (2023)

PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8
por: Chang, Xiao-tian, et al.
Publicado: (2022)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

LncRNA SPRY4‑IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro
por: Sang, Weicong, et al.
Publicado: (2023)

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
por: Banerjee, Rajat, et al.
Publicado: (2014)

TRIP13(PCH-2) promotes Mad2 localization to unattached kinetochores in the spindle checkpoint response
por: Nelson, Christian R., et al.
Publicado: (2015)

p31(comet) promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase
por: Sarangi, Prabha, et al.
Publicado: (2020)

Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT
por: Ma, Tao, et al.
Publicado: (2019)

Upregulation of LSD1 promotes migration and invasion in gastric cancer through facilitating EMT
por: Zhang, Jin, et al.
Publicado: (2019)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway: CENPM promotes lung adenocarcinoma progression
por: Liu, Chao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9241260ci9ju7mr88plk7ahq0r